REPORT ID 2744

EMEA (Europe, Middle East and Africa) DT-Based Combined Vaccines Market Report 2017

Publish Date
11-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the EMEA DT-Based Combined Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of DT-Based Combined Vaccines for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA DT-Based Combined Vaccines market competition by top manufacturers/players, with DT-Based Combined Vaccines sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Changsheng
    CCBIO
    Aleph Biomedical
    Sanofi
    Lanzhou Institute Of Biological Product
    Siobp
    Hualan Bio
    Tianyuan Bio-Pharma
    Vaxtec
    Hissen
    Abbott
    Novartis
    Tasly&Jenner
    Tiantan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Protect Against Two or More Diseases
    Protect Against One Disease Caused by Different Strains or Serotypes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Children
    Adults
    Elderly
    Pregnancy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) DT-Based Combined Vaccines Market Report 2017
1 DT-Based Combined Vaccines Overview
    1.1 Product Overview and Scope of DT-Based Combined Vaccines
    1.2 Classification of DT-Based Combined Vaccines
        1.2.1 EMEA DT-Based Combined Vaccines Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA DT-Based Combined Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Protect Against Two or More Diseases
        1.2.4 Protect Against One Disease Caused by Different Strains or Serotypes
    1.3 EMEA DT-Based Combined Vaccines Market by Application/End Users
        1.3.1 EMEA DT-Based Combined Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Children
        1.3.3 Adults
        1.3.4 Elderly
        1.3.5 Pregnancy
    1.4 EMEA DT-Based Combined Vaccines Market by Region
        1.4.1 EMEA DT-Based Combined Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of DT-Based Combined Vaccines (2012-2022)
        1.5.1 EMEA DT-Based Combined Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 EMEA DT-Based Combined Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA DT-Based Combined Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA DT-Based Combined Vaccines Market Competition by Players/Manufacturers
        2.1.1 EMEA DT-Based Combined Vaccines Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA DT-Based Combined Vaccines Revenue and Share by Players (2012-2017)
        2.1.3 EMEA DT-Based Combined Vaccines Sale Price by Players (2012-2017)
    2.2 EMEA DT-Based Combined Vaccines (Volume and Value) by Type/Product Category
        2.2.1 EMEA DT-Based Combined Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA DT-Based Combined Vaccines Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA DT-Based Combined Vaccines Sale Price by Type (2012-2017)
    2.3 EMEA DT-Based Combined Vaccines (Volume) by Application
    2.4 EMEA DT-Based Combined Vaccines (Volume and Value) by Region
        2.4.1 EMEA DT-Based Combined Vaccines Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA DT-Based Combined Vaccines Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA DT-Based Combined Vaccines Sales Price by Region (2012-2017)

3 Europe DT-Based Combined Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe DT-Based Combined Vaccines Sales and Value (2012-2017)
        3.1.1 Europe DT-Based Combined Vaccines Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe DT-Based Combined Vaccines Revenue and Growth Rate (2012-2017)
    3.2 Europe DT-Based Combined Vaccines Sales and Market Share by Type
    3.3 Europe DT-Based Combined Vaccines Sales and Market Share by Application
    3.4 Europe DT-Based Combined Vaccines Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe DT-Based Combined Vaccines Sales Volume by Countries (2012-2017)
        3.4.2 Europe DT-Based Combined Vaccines Revenue by Countries (2012-2017)
        3.4.3 Germany DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        3.4.4 France DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        3.4.5 UK DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        3.4.6 Russia DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        3.4.7 Italy DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        3.4.8 Benelux DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)

4 Middle East DT-Based Combined Vaccines (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East DT-Based Combined Vaccines Sales and Value (2012-2017)
        4.1.1 Middle East DT-Based Combined Vaccines Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East DT-Based Combined Vaccines Revenue and Growth Rate (2012-2017)
    4.2 Middle East DT-Based Combined Vaccines Sales and Market Share by Type
    4.3 Middle East DT-Based Combined Vaccines Sales and Market Share by Application
    4.4 Middle East DT-Based Combined Vaccines Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East DT-Based Combined Vaccines Sales Volume by Countries (2012-2017)
        4.4.2 Middle East DT-Based Combined Vaccines Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        4.4.4 Israel DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        4.4.5 UAE DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        4.4.6 Iran DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)

5 Africa DT-Based Combined Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa DT-Based Combined Vaccines Sales and Value (2012-2017)
        5.1.1 Africa DT-Based Combined Vaccines Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa DT-Based Combined Vaccines Revenue and Growth Rate (2012-2017)
    5.2 Africa DT-Based Combined Vaccines Sales and Market Share by Type
    5.3 Africa DT-Based Combined Vaccines Sales and Market Share by Application
    5.4 Africa DT-Based Combined Vaccines Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa DT-Based Combined Vaccines Sales Volume by Countries (2012-2017)
        5.4.2 Africa DT-Based Combined Vaccines Revenue by Countries (2012-2017)
        5.4.3 South Africa DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        5.4.5 Egypt DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)
        5.4.6 Algeria DT-Based Combined Vaccines Sales and Growth Rate (2012-2017)

6 EMEA DT-Based Combined Vaccines Manufacturers/Players Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Changsheng
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Changsheng DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 CCBIO
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 CCBIO DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Aleph Biomedical
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Aleph Biomedical DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Sanofi
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Sanofi DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Lanzhou Institute Of Biological Product
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Siobp
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Siobp DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Hualan Bio
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Hualan Bio DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Tianyuan Bio-Pharma
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Tianyuan Bio-Pharma DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Vaxtec
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 DT-Based Combined Vaccines Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Vaxtec DT-Based Combined Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Hissen
    6.12 Abbott
    6.13 Novartis
    6.14 Tasly&Jenner
    6.15 Tiantan

7 DT-Based Combined Vaccines Manufacturing Cost Analysis
    7.1 DT-Based Combined Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of DT-Based Combined Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 DT-Based Combined Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of DT-Based Combined Vaccines Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA DT-Based Combined Vaccines Market Forecast (2017-2022)
    11.1 EMEA DT-Based Combined Vaccines Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA DT-Based Combined Vaccines Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA DT-Based Combined Vaccines Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA DT-Based Combined Vaccines Price and Trend Forecast (2017-2022)
    11.2 EMEA DT-Based Combined Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe DT-Based Combined Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt DT-Based Combined Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa DT-Based Combined Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA DT-Based Combined Vaccines Sales Forecast by Type (2017-2022)
    11.7 EMEA DT-Based Combined Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer